Clinical stage Bo or T1c prostate cancer: Nonpalpable disease identified by elevated serum prostate-specific antigen concentration
- 31 January 1993
- journal article
- Published by Elsevier BV in Urology
- Vol. 41 (1), 3-8
- https://doi.org/10.1016/0090-4295(93)90233-z
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Prostate Cancer: Correlation Of Digital Rectal Examination, Transrectal Ultrasound And Prostate Specific Antigen Levels With Tumor Volumes In Radical Prostatectomy SpecimensJournal of Urology, 1990
- Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific AntigenJournal of Urology, 1990
- Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign HyperplasiaJournal of Urology, 1990
- Clinical use of Prostate Specific Antigen in Patients with Prostate CancerJournal of Urology, 1989
- Unsuspected Adenocarcinoma of the Prostate in Patients Undergoing Cystoprostatectomy for other Causes: Incidence, Histology and Morphometric ObservationsJournal of Urology, 1989
- The Value of Serum Prostate Specific Antigen Determinations Before and after Radical ProstatectomyJournal of Urology, 1989
- Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancerCancer, 1989
- Screening for Prostatic Cancer with High-Resolution UltrasoundJournal of Endourology, 1989
- Prostate cancer: comparison of transrectal US and digital rectal examination for screening.Radiology, 1988